114 related articles for article (PubMed ID: 18020912)
41. "Personalizing" therapy for non-small cell lung cancer.
D'Cunha J
Semin Thorac Cardiovasc Surg; 2010; 22(2):118-20. PubMed ID: 21092888
[TBL] [Abstract][Full Text] [Related]
42. DNA microarray technology in cancer research.
Rew DA
Eur J Surg Oncol; 2001 Aug; 27(5):504-8. PubMed ID: 11504524
[TBL] [Abstract][Full Text] [Related]
43. Refining prognosis in non-small-cell lung cancer.
Larsen JE; Fong KM; Hayward NK
N Engl J Med; 2007 Jan; 356(2):190; author reply 190-1. PubMed ID: 17225285
[No Abstract] [Full Text] [Related]
44. Profiles in variation: lung carcinogenesis.
Carbone DP
Cancer Prev Res (Phila); 2009 Aug; 2(8):695-7. PubMed ID: 19638487
[TBL] [Abstract][Full Text] [Related]
45. Why most gene expression signatures of tumors have not been useful in the clinic.
Koscielny S
Sci Transl Med; 2010 Jan; 2(14):14ps2. PubMed ID: 20371465
[TBL] [Abstract][Full Text] [Related]
46. Molecular prognostication of liver cancer: end of the beginning.
Thorgeirsson SS; Lee JS; Grisham JW
J Hepatol; 2006 Apr; 44(4):798-805. PubMed ID: 16488507
[No Abstract] [Full Text] [Related]
47. Gene profiling in breast cancer: time to move forward.
Espinosa E; Vara JÁ; Navarro IS; Gámez-Pozo A; Pinto A; Zamora P; Redondo A; Feliu J
Cancer Treat Rev; 2011 Oct; 37(6):416-21. PubMed ID: 21277684
[TBL] [Abstract][Full Text] [Related]
48. Genomic strategies for personalized cancer therapy.
Garman KS; Nevins JR; Potti A
Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R226-32. PubMed ID: 17911165
[TBL] [Abstract][Full Text] [Related]
49. The prospect of biologic staging of non-small-cell lung cancer.
Sardari Nia P; Van Marck E; Van Schil P
Clin Lung Cancer; 2005 Jan; 6(4):217-24. PubMed ID: 15694013
[TBL] [Abstract][Full Text] [Related]
50. Selective discussion and transparency in microarray research findings for cancer outcomes.
Ioannidis JP; Polyzos NP; Trikalinos TA
Eur J Cancer; 2007 Sep; 43(13):1999-2010. PubMed ID: 17629475
[TBL] [Abstract][Full Text] [Related]
51. Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
Bild AH; Yao G; Chang JT; Wang Q; Potti A; Chasse D; Joshi MB; Harpole D; Lancaster JM; Berchuck A; Olson JA; Marks JR; Dressman HK; West M; Nevins JR
Nature; 2006 Jan; 439(7074):353-7. PubMed ID: 16273092
[TBL] [Abstract][Full Text] [Related]
52. Predicting response to radiotherapy: evolutions and revolutions.
Begg AC
Int J Radiat Biol; 2009; 85(10):825-36. PubMed ID: 19863199
[TBL] [Abstract][Full Text] [Related]
53. Genomic signatures in non-small-cell lung cancer: targeting the targeted therapies.
Dressman HK; Bild A; Garst J; Harpole D; Potti A
Curr Oncol Rep; 2006 Jul; 8(4):252-7. PubMed ID: 17254524
[TBL] [Abstract][Full Text] [Related]
54. A checklist for evaluating reports of expression profiling for treatment selection.
Simon R
Clin Adv Hematol Oncol; 2006 Mar; 4(3):219-24. PubMed ID: 16728933
[TBL] [Abstract][Full Text] [Related]
55. Multi-gene expression-based statistical approaches to predicting patients' clinical outcomes and responses.
Cheng F; Cho SH; Lee JK
Methods Mol Biol; 2010; 620():471-84. PubMed ID: 20652516
[TBL] [Abstract][Full Text] [Related]
56. Do predictive signatures really predict response to cancer chemotherapy?
Borst P; Wessels L
Cell Cycle; 2010 Dec; 9(24):4836-40. PubMed ID: 21150277
[TBL] [Abstract][Full Text] [Related]
57. Genomic signatures to guide the use of chemotherapeutics.
Potti A; Dressman HK; Bild A; Riedel RF; Chan G; Sayer R; Cragun J; Cottrill H; Kelley MJ; Petersen R; Harpole D; Marks J; Berchuck A; Ginsburg GS; Febbo P; Lancaster J; Nevins JR
Nat Med; 2006 Nov; 12(11):1294-300. PubMed ID: 17057710
[TBL] [Abstract][Full Text] [Related]
58. Pathway-based classification of lung cancer: a strategy to guide therapeutic selection.
Nevins JR
Proc Am Thorac Soc; 2011 May; 8(2):180-2. PubMed ID: 21543798
[TBL] [Abstract][Full Text] [Related]
59. What should physicians look for in evaluating prognostic gene-expression signatures?
Subramanian J; Simon R
Nat Rev Clin Oncol; 2010 Jun; 7(6):327-34. PubMed ID: 20421890
[TBL] [Abstract][Full Text] [Related]
60. [Predictive pathology: concept and dimensions of clinical trials].
Schölmerich J
Verh Dtsch Ges Pathol; 2006; 90():52-8. PubMed ID: 17867580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
